Thermo Fisher Scientific is set to acquire Clario Holdings after entering a $8.8 billion definitive agreement, which includes ...
Lilly and NVIDIA’s supercomputer marks the world's first NVIDIA DGX SuperPOD with DGX B300 systems, and is powered by more than 1,000 B300 GPUs on a unified networking fabric, meaning communication ...
Marcel Botha, CEO of 10XBeta, discusses FDA’s new pilot authorization program for abbreviated new drug applications (ANDA) and what impact it will have on manufacturing and the supply chain.
Marcel Botha, CEO of 10XBeta, discusses FDA’s new pilot authorization program for abbreviated new drug applications (ANDA) ...
PE: What impact will DTC programs have on generic drug prices? O’Dell: Not much today, but generics are not completely immune ...
Eli Lilly and Walmart Pharmacy collaborate to offer Zepbound vials through LillyDirect, enhancing patient access and convenience. Patients with valid prescriptions can access Zepbound without ...
In today’s Pharmaceutical Executive Daily, we cover the resignation of Organon CEO Kevin Ali following an internal investigation tied to Nexplanon sales, GSK’s $357 million agreement with Syndivia to ...
Shortly following the announcement of its acquisition of Syndivia’s ADC, GSK entered into a worldwide exclusive license ...
The FDA has approved a new single-injection, once-monthly maintenance regimen for Eli Lilly’s Omvoh (mirikizumab-mrkz), ...
PE: What impact will DTC programs have on generic drug prices? O’Dell: Not much today, but generics are not completely immune ...
GSK is set to acquire the exclusive rights for Syndivia’s preclinical antibody-drug conjugate (ADC), which is currently in ...
Novartis will acquire Avidity Biosciences in a newly announced definitive merger agreement. The news follows the separation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback